In GBM cells, miR-1297 repressed cell proliferation and glycolysis via targeting KPNA2 (77), a high oncogene in glioma tissues that was proven to be a high promoter of glycolytic metabolism in GBM cells as well (78). The gene discussed is KPNA2; the disease is central nervous system cancer.